These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22744640)

  • 1. Overview of personalized medicine in GI cancers.
    Chao C
    J Gastrointest Surg; 2012 Sep; 16(9):1641-4. PubMed ID: 22744640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets in GI malignancies - A pathologist's perspective.
    Pawar S; Sharma A
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S43-S51. PubMed ID: 34135137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiles in foregut oncology.
    Sukharamwala P; Hennessey D; Wood T; Singh S; Ryan C; Rosemurgy A
    Cancer Genet; 2016 Dec; 209(12):537-553. PubMed ID: 27887938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
    Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
    [No Abstract]   [Full Text] [Related]  

  • 6. Ushering in the Era of Precision Medicine.
    Oncology (Williston Park); 2020 Aug; 34(8):314-316. PubMed ID: 32785927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.
    Giordani E; Zoratto F; Strudel M; Papa A; Rossi L; Minozzi M; Caruso D; Zaccarelli E; Verrico M; Tomao S
    Curr Cancer Drug Targets; 2016; 16(2):175-85. PubMed ID: 26278713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
    Baraniskin A; Van Laethem JL; Wyrwicz L; Guller U; Wasan HS; Matysiak-Budnik T; Gruenberger T; Ducreux M; Carneiro F; Van Cutsem E; Seufferlein T; Schmiegel W
    Eur J Cancer; 2017 Nov; 86():305-317. PubMed ID: 29065378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personalized therapy of gastrointestinal cancers--possibilities and limitations].
    Wichert Gv; Adler G; Seufferlein T
    Dtsch Med Wochenschr; 2010 Aug; 135(34-35):1687-91. PubMed ID: 20721844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current state of molecular profiling in gastrointestinal malignancies.
    Mukherji R; Yin C; Hameed R; Alqahtani AZ; Kulasekaran M; He AR; Weinberg BA; Marshall JL; Hartley ML; Noel MS
    Biol Direct; 2022 Jun; 17(1):15. PubMed ID: 35668531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
    Cheng Y; Qin SK; Li J; Dai GH; Shen BY; Ying JE; Ba Y; Liang H; Wang XB; Xu Y; Zhou L; Ding KF; Qin YR; Yang SJ; Guan WX; Zheng H; Wang Q; Song H; Zhu YP
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):673-684. PubMed ID: 33864522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer.
    Memarpour S; Khalili-Tanha G; Ghannad AA; Razavi MS; Joudi M; Joodi M; Ferns GA; Hassanian SM; Khazaei M; Avan A
    Curr Cancer Drug Targets; 2021; 21(8):676-688. PubMed ID: 33719973
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Li L; Li M; Jiang Z; Wang X
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine in Gastrointestinal Pathology.
    Wang DH; Park JY
    Arch Pathol Lab Med; 2016 May; 140(5):449-60. PubMed ID: 27128302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GI cancers in 2010: New standards and a predictive biomarker for adjuvant therapy.
    Sharma MR; Schilsky RL
    Nat Rev Clin Oncol; 2011 Feb; 8(2):70-2. PubMed ID: 21278772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine.
    Piroozkhah M; Gholinezhad Y; Piroozkhah M; Shams E; Nazemalhosseini-Mojarad E
    Front Immunol; 2023; 14():1298891. PubMed ID: 38077386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Personalized tumor therapy for gastrointestinal tumors].
    Ettrich TJ; Perkhofer L; Seufferlein T
    Internist (Berl); 2015 Sep; 56(9):1069-78. PubMed ID: 26148698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIDB: a knowledge database for the automated curation and multidimensional analysis of molecular signatures in gastrointestinal cancer.
    Wang Y; Wang Y; Wang S; Tong Y; Jin L; Zong H; Zheng R; Yang J; Zhang Z; Ouyang E; Zhou M; Zhang X
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31089686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.
    Lamarca A; Morfouace M; Tejpar S; Oliveira J; Capela A; Penel N; Gennigens C; Brasiuniene B; Peron J; Stevovic A; Blay JY; Klümpen HJ
    Ann Oncol; 2022 Nov; 33(11):1200-1202. PubMed ID: 35926814
    [No Abstract]   [Full Text] [Related]  

  • 20. [Not Available].
    Søreide K
    Tidsskr Nor Laegeforen; 2018 Oct; 138(15):. PubMed ID: 30277036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.